| Field | Row 1 |
|---|---|
| adsh | 0001654954-25-005701 |
| cik | 1392449 |
| name | GREEN PLANET BIO ENGINEERING CO. LTD. |
| sic | 2836 |
| countryba | US |
| stprba | FL |
| cityba | AVENTURA |
| zipba | 33180 |
| bas1 | 20807 BISCAYNE BLVD. |
| bas2 | SUITE 203 |
| baph | 786-279-2900 |
| countryma | US |
| stprma | FL |
| cityma | AVENTURA |
| zipma | 33180 |
| mas1 | 20807 BISCAYNE BLVD. |
| mas2 | SUITE 203 |
| countryinc | |
| stprinc | |
| ein | 371532842 |
| former | MONDO ACQUISITION II, INC. |
| changed | 20070308 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 12:14:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | gplb_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001654954-25-005701 | 20250331 | Accounts Payable And Accrued Liabilities Current | 5425.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20250331 | Shares Issued | 20006402.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20250331 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Common Stock Shares Issued | 20006402.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Liabilities Current | 471974.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Cash Provided By Used In Financing Activities | 7965.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Income Loss | -6465.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Income Loss | -6465.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001654954-25-005701 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001654954-25-005701 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001654954-25-005701 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Proceeds From Related Party Debts | 6915.0000 | USD | 1 | 0001654954-25-005701 | |||
| 0001654954-25-005701 | 20240331 | Stockholders Equity | -1065675.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001654954-25-005701 | 20241231 | Stockholders Equity | -465134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Stockholders Equity | 609614.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001654954-25-005701 | 20250331 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Income Taxes Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | General And Administrative Expense | 6465.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | General And Administrative Expense | 6840.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Additional Paid In Capital | 609614.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Accounts Payable And Accrued Liabilities Current | 5500.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Income Taxes Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Net Cash Provided By Used In Financing Activities | 6915.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001654954-25-005701 | 20250331 | Net Income Loss | -6840.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001654954-25-005701 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Retained Earnings Accumulated Deficit | -1101594.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20231231 | Stockholders Equity | -1059210.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001654954-25-005701 | 20241231 | Stockholders Equity | 20006.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001654954-25-005701 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 20006402.0000 | shares | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Additional Paid In Capital | 609614.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -6840.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001654954-25-005701 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Profit Loss | -6465.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Profit Loss | -6840.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20231231 | Stockholders Equity | 20006.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001654954-25-005701 | 20240331 | Stockholders Equity | 20006.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20250331 | Stockholders Equity | 20006.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20241231 | Amount Due To Related Party Current | 459634.0000 | USD | 0 | 0001654954-25-005701 | |||
| 0001654954-25-005701 | 20250331 | Amount Due To Related Party Current | 466549.0000 | USD | 0 | 0001654954-25-005701 | |||
| 0001654954-25-005701 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1500.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001654954-25-005701 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20231231 | Stockholders Equity | -429590.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20231231 | Stockholders Equity | 609614.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001654954-25-005701 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 20006402.0000 | shares | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Common Stock Shares Issued | 20006402.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Common Stock Shares Outstanding | 20006402.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Common Stock Value | 20006.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Liabilities Current | 465134.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Net Cash Provided By Used In Operating Activities | -7965.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Net Income Loss | -6840.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001654954-25-005701 | 20240331 | Proceeds From Related Party Debts | 7965.0000 | USD | 1 | 0001654954-25-005701 | |||
| 0001654954-25-005701 | 20241231 | Retained Earnings Accumulated Deficit | -1094754.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Stockholders Equity | -436055.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Stockholders Equity | -471974.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Stockholders Equity | 609614.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001654954-25-005701 | 20250331 | Stockholders Equity | -1101594.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001654954-25-005701 | 20241231 | Assets Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20241231 | Common Stock Shares Outstanding | 20006402.0000 | shares | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Common Stock Value | 20006.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -6465.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -75.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Liabilities And Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Net Cash Provided By Used In Operating Activities | -6915.0000 | USD | 1 | us-gaap/2024 | |||
| 0001654954-25-005701 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001654954-25-005701 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001654954-25-005701 | 20231231 | Shares Issued | 20006402.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20240331 | Shares Issued | 20006402.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20241231 | Shares Issued | 20006402.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001654954-25-005701 | 20240331 | Stockholders Equity | 609614.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001654954-25-005701 | 20241231 | Stockholders Equity | -1094754.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Proceeds From Related Party Debts | 0001654954-25-005701 | 1 | 0 | monetary | D | D | Amount due to a related company | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Income Taxes Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid | Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Amount Due To Related Party Current | 0001654954-25-005701 | 1 | 0 | monetary | I | C | Amount due to a related party |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001654954-25-005701 | 2 | 1 | BS | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash | 0 |
| 0001654954-25-005701 | 2 | 2 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001654954-25-005701 | 2 | 4 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001654954-25-005701 | 2 | 5 | BS | 0 | H | Amount Due To Related Party Current | 0001654954-25-005701 | Amount due to a related party | 0 |
| 0001654954-25-005701 | 2 | 6 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001654954-25-005701 | 2 | 8 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock value | 0 |
| 0001654954-25-005701 | 2 | 9 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock value | 0 |
| 0001654954-25-005701 | 2 | 10 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001654954-25-005701 | 2 | 11 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001654954-25-005701 | 2 | 12 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS' DEFICIT | 0 |
| 0001654954-25-005701 | 2 | 13 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 0 |
| 0001654954-25-005701 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred Stock, Par Value | 0 |
| 0001654954-25-005701 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred Stock, Authorized | 0 |
| 0001654954-25-005701 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred Stock, Issued | 0 |
| 0001654954-25-005701 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred Stock, Outstanding | 0 |
| 0001654954-25-005701 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common Stock, Par Value | 0 |
| 0001654954-25-005701 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common Stock, Authorized | 0 |
| 0001654954-25-005701 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common Stock, Issued | 0 |
| 0001654954-25-005701 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common Stock, Outstanding | 0 |
| 0001654954-25-005701 | 4 | 1 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | Administrative expenses | 1 |
| 0001654954-25-005701 | 4 | 2 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001654954-25-005701 | 4 | 3 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 0 |
| 0001654954-25-005701 | 4 | 4 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 0 |
| 0001654954-25-005701 | 4 | 6 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | -Basic and diluted | 0 |
| 0001654954-25-005701 | 4 | 7 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | -Basic and diluted | 0 |
| 0001654954-25-005701 | 5 | 9 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001654954-25-005701 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001654954-25-005701 | 5 | 11 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss for the three months | 0 |
| 0001654954-25-005701 | 5 | 12 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001654954-25-005701 | 5 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001654954-25-005701 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001654954-25-005701 | 6 | 4 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued liabilities | 0 |
| 0001654954-25-005701 | 6 | 5 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash flows used by operating activities | 0 |
| 0001654954-25-005701 | 6 | 6 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Cash flows from investing activities | 0 |
| 0001654954-25-005701 | 6 | 8 | CF | 0 | H | Proceeds From Related Party Debts | 0001654954-25-005701 | Amount due to a related company | 0 |
| 0001654954-25-005701 | 6 | 9 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash flows provided by financing activities | 0 |
| 0001654954-25-005701 | 6 | 10 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net change in cash | 0 |
| 0001654954-25-005701 | 6 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash - beginning of period | 0 |
| 0001654954-25-005701 | 6 | 12 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash - end of period | 0 |
| 0001654954-25-005701 | 6 | 14 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001654954-25-005701 | 6 | 15 | CF | 0 | H | Income Taxes Paid | us-gaap/2024 | Cash paid for income taxes | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |